Which has grown faster, DH or IMDX?

Over the past five years, IMDX grew revenue faster — DH at a 10.62% CAGR versus IMDX at 27.24%.

How have DH and IMDX total returns compared?

Over the past 5 years, DH delivered -52.54% and IMDX delivered -44.39% annualized total return. Past performance doesn't predict future results.

Definitive Healthcare Corp. (DH) vs Insight Molecular Diagnostics Inc. (IMDX)

A side-by-side comparison of Definitive Healthcare Corp. and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Definitive Healthcare Corp.

$105M

$1.00HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

IMDX

Insight Molecular Diagnostics Inc.

$113M

$3.49HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT

Total return — DH vs IMDX

growth of $100 · dividends reinvested · last 5y

DH -97.7% (-53.1%/yr)IMDX -94.9% (-45.0%/yr)IMDX compounded faster over this window

DH IMDX

DH vs IMDX: by the numbers

•IMDX is the larger company ($113M vs $105M market cap).
•Both run net losses; DH's is the smaller (-72.28% vs -2955.63% net margin).
•IMDX grew revenue faster over the past five years (27.24% vs 10.62% CAGR).

Metrics side by side

Valuation

Metric	DH	IMDX
Forward P/E	5.11	N/A
P/S ratio	0.45	67.48
P/B ratio	0.73	N/A
EV / EBITDA	0.49	N/A
FCF yield	27.20%	N/A

Profitability

Metric	DH	IMDX
Gross margin	71.67%	11.17%
Operating margin	-8.52%	-754.08%
Net margin	-72.28%	-2955.63%
ROE	-116.28%	N/A
ROIC	41.64%	-223.06%

Growth (annualized)

Metric	DH	IMDX
Revenue CAGR (5Y)	10.62%	27.24%
FCF CAGR (5Y)	2.14%	N/A
Total return CAGR (5Y)	-52.54%	-44.39%

Frequently asked

Which has grown faster, DH or IMDX?: Over the past five years, IMDX grew revenue faster — DH at a 10.62% CAGR versus IMDX at 27.24%.
How have DH and IMDX total returns compared?: Over the past 5 years, DH delivered -52.54% and IMDX delivered -44.39% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DH analysis Full IMDX analysis Interactive comparison tool

Dig into the metrics

Definitive Healthcare ROE Insight Molecular Diagnostics ROE Definitive Healthcare operating margin Insight Molecular Diagnostics operating margin Definitive Healthcare revenue growth Insight Molecular Diagnostics revenue growth Definitive Healthcare free cash flow Insight Molecular Diagnostics free cash flow

Definitive Healthcare & Insight Molecular Diagnostics appear in these rankings

Fastest Revenue Growth Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.